207 related articles for article (PubMed ID: 2176428)
1. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
[TBL] [Abstract][Full Text] [Related]
2. A case of the watery diarrhea-hypokalemia-achlorhydria syndrome: successful preoperative treatment of watery diarrhea with a somatostatin analogue.
Yoshioka M; Sakazume M; Fukagawa M; Seki T; Honma K; Uchida K; Yoshida K; Miyake Y; Yamaguchi K
Jpn J Clin Oncol; 1989 Sep; 19(3):294-8. PubMed ID: 2554028
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of pancreatic cholera: a case report.
Kirkpatrick AW; Hanna SS; Skinner BA
Can J Surg; 1996 Apr; 39(2):155-8. PubMed ID: 8769928
[TBL] [Abstract][Full Text] [Related]
4. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
Christensen C
Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995).
Niitsu Y; Goto Y; Maeda M; Tsushima N; Watanabe N; Kohgo Y; Urushizaki I
Aliment Pharmacol Ther; 1988 Jun; 2(3):269-79. PubMed ID: 2856504
[TBL] [Abstract][Full Text] [Related]
6. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
Flückiger A; Schlup P
Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
[TBL] [Abstract][Full Text] [Related]
7. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide].
Scheffold N; Arnold R; Cyran J
Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006
[TBL] [Abstract][Full Text] [Related]
8. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
10. Four year treatment with a long acting somatostatin analogue in a patient with Verner-Morrison syndrome.
Brunani A; Crespi C; De Martin M; Dubini A; Piolini M; Cavagnini F
J Endocrinol Invest; 1991 Sep; 14(8):685-9. PubMed ID: 1663530
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic Vipoma by liver transplantation.
Bramley PN; Lodge JP; Losowsky MS; Giles GR
Clin Transplant; 1990 Oct; 4(5 part 1):276-8; discussion 279. PubMed ID: 10150088
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
Shaib W; Mitchell K; Saif MW
Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
Juby LD; Burke DA; Axon AT
Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
[TBL] [Abstract][Full Text] [Related]
14. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
[TBL] [Abstract][Full Text] [Related]
15. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
Christensen C
Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
[TBL] [Abstract][Full Text] [Related]
16. [Paralytic ileus as an initial manifestation of malignant VIPoma of the pancreas--case report with review of the literature].
Koberstein B; Eysselein VE; Balzer K; Müller MK; Eberlein G; Singer MV; Willemer S; Adler G; Goebell H
Z Gastroenterol; 1990 Jun; 28(6):295-301. PubMed ID: 1978446
[TBL] [Abstract][Full Text] [Related]
17. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
18. Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours.
Lamberts SW; Pieters GF; Metselaar HJ; Ong GL; Tan HS; Reubi JC
Acta Endocrinol (Copenh); 1988 Dec; 119(4):561-6. PubMed ID: 2849276
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
[TBL] [Abstract][Full Text] [Related]
20. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
